Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label give a damn. Show all posts
Showing posts with label give a damn. Show all posts

Monday, November 15, 2021

European evidence-based recommendations for clinical assessment of upper limb in neurorehabilitation (CAULIN): data synthesis from systematic reviews, clinical practice guidelines and expert consensus

Oh for fucks sake, this is totally useless, not one survivor gives a damn about your assessments. I'd have your asses fired in no time.   The only goal in stroke is 100% recovery, this does nothing for that.

Give us EXACT STROKE PROTOCOLS PRODUCING EXACT RESULTS.

European evidence-based recommendations for clinical assessment of upper limb in neurorehabilitation (CAULIN): data synthesis from systematic reviews, clinical practice guidelines and expert consensus

Abstract

Background

Technology-supported rehabilitation can help alleviate the increasing need for cost-effective rehabilitation of neurological conditions, but use in clinical practice remains limited. Agreement on a core set of reliable, valid and accessible outcome measures to assess rehabilitation outcomes is needed to generate strong evidence about effectiveness of rehabilitation approaches, including technologies. This paper collates and synthesizes a core set from multiple sources; combining existing evidence, clinical practice guidelines and expert consensus into European recommendations for Clinical Assessment of Upper Limb In Neurorehabilitation (CAULIN).

Methods

Data from systematic reviews, clinical practice guidelines and expert consensus (Delphi methodology) were systematically extracted and synthesized using strength of evidence rating criteria, in addition to recommendations on assessment procedures. Three sets were defined: a core set: strong evidence for validity, reliability, responsiveness and clinical utility AND recommended by at least two sources; an extended set: strong evidence OR recommended by at least two sources and a supplementary set: some evidence OR recommended by at least one of the sources.

Results

In total, 12 measures (with primary focus on stroke) were included, encompassing body function and activity level of the International Classification of Functioning and Health. The core set recommended for clinical practice and research: Fugl-Meyer Assessment of Upper Extremity (FMA-UE) and Action Research Arm Test (ARAT); the extended set recommended for clinical practice and/or clinical research: kinematic measures, Box and Block Test (BBT), Chedoke Arm Hand Activity Inventory (CAHAI), Wolf Motor Function Test (WMFT), Nine Hole Peg Test (NHPT) and ABILHAND; the supplementary set recommended for research or specific occasions: Motricity Index (MI); Chedoke-McMaster Stroke Assessment (CMSA), Stroke Rehabilitation Assessment Movement (STREAM), Frenchay Arm Test (FAT), Motor Assessment Scale (MAS) and body-worn movement sensors. Assessments should be conducted at pre-defined regular intervals by trained personnel. Global measures should be applied within 24 h of hospital admission and upper limb specific measures within 1 week.

Conclusions

The CAULIN recommendations for outcome measures and assessment procedures provide a clear, simple, evidence-based three-level structure for upper limb assessment in neurological rehabilitation. Widespread adoption and sustained use will improve quality of clinical practice and facilitate meta-analysis, critical for the advancement of technology-supported neurorehabilitation.

Background

Neurological conditions are a leading cause of disability world-wide. Incidence is rising due to an ageing world population and prevalence is increasing due to growth of the world population, better survival rates and improved long-term care [1]. The result is increasing pressure on the healthcare system globally and frames the need for effective and efficient approaches to enable and maintain access to care.

Recent advances in neurorehabilitation research have resulted in a better understanding of recovery, giving rise to new promising approaches such as increased intensity of practice, early intervention and use of technology. Of those, the use of technology in rehabilitation may help alleviate the pressure on the healthcare system. Moreover, technologies could enable access to rehabilitation throughout the lifespan and has been advocated by the World Health Organisation (WHO) as an investment in human capital that contributes to health, economic and social development [2].

For a successful transfer of therapeutic interventions using rehabilitation technology into clinical practice, evidence of their effectiveness is essential. This is reflected in national strategies and frameworks emphasising the need for informed decision making in healthcare that is research-led and evidence-based. Yet, several national guidelines cite limited research evidence to justify the use of rehabilitation technologies [3,4,5]. Indeed, data on clinical evaluations of interventions in neurological rehabilitation, either conventional or technological, are not easily comparable due to inconsistency in what is actually measured [2], and the measurement tools used. Consequently, there is a paucity of high-quality evidence from systematic reviews and meta-analyses [6].

Agreement on outcome measures (OM) and corresponding procedures for assessment are critical to advancing the field. For new approaches to be used effectively in clinical practice (the right therapy approach with the right patients, at the right time and delivered via the most effective protocols), clinicians need clear assessment guidelines to enable them to make informed decisions. The use of agreed, uniform OM is not only useful in order to compare the effectiveness of different training approaches, but also to identify which patients benefit most from which training approach and dose.

For example, the use of different technologies for task-oriented training of the upper limb was investigated in highly functional chronic stroke patients in two separate clinical trials using a sensor system [7] or a robot system [8]. As both studies used the same OM, results could be combined, showing that training with the inertial sensor system providing feedback on exercise performance was more beneficial for highly functional patients than the robot-guided system [9].

In addition, practical and accurate tools are emerging that can predict recovery, with the potential to significantly improve patient management and reduce costs of health services [10]. Establishing and elaborating clinical prediction models for the upper limb, such as SAFE [11] and PREP2 [12], to facilitate personalisation of patient rehabilitation and discharge planning, can only occur if sufficient good quality objective assessment data is available.

The European Network on Robotics for Neurorehabilitation (European Co-operation in Science and Technology, COST Action TD1006) has developed a set of recommendations for upper limb assessment in neurological conditions, to evaluate both conventional and technology-supported therapy. These European recommendations aim to improve the quality of upper limb neurorehabilitation in clinical practice globally, through the adoption of standardised, agreed protocols for assessment in clinical practice and research. The recommendations will directly support clinical research and facilitate larger scale multi-centre studies, allowing meta-analyses, essential for informing and stimulating investigation of prediction for patient-specific training approaches and more generally advancing understanding of recovery. It will also inform and influence the development of new upper limb neurorehabilitation technologies both as therapies and assessment tools, and assist in the translation of useful technologies into clinical practice.

The present paper collates and synthesizes the recommendations from multiple sources, combining existing evidence, current clinical practice guidelines and expert consensus, into the recommendations for Clinical Assessment of Upper Limb In Neurorehabilitation (CAULIN). The CAULIN recommendations provide evidence-based recommendations for upper limb assessment of patients with neurological conditions before, during and after therapy (either conventional or technology-assisted treatment), including the recommended time frame of applying structured assessment where available.

More at link.

 

Thursday, August 26, 2021

Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis

 You blithering idiots, the endpoint to measure is 100% recovery, NOT recanalization. You actually think survivors give a gamn about recanalization? Recanalization is only an intermediate step, stopping there is akin to medical malpractice.

Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis

Originally publishedhttps://doi.org/10.1161/STROKEAHA.120.030960Stroke. ;0:STROKEAHA.120.030960

Background and Purpose:

Evidence about the utility of ultrasound-enhanced thrombolysis (sonothrombolysis) in patients with acute ischemic stroke (AIS) is conflicting. We aimed to evaluate the safety and efficacy of sonothrombolysis in patients with AIS with large vessel occlusion, by analyzing individual patient data of available randomized-controlled clinical trials.

Methods:

We included all available randomized-controlled clinical trials comparing sonothrombolysis with or without addition of microspheres (treatment group) to intravenous thrombolysis alone (control group) in patients with AIS with large vessel occlusion. The primary outcome measure was the rate of complete recanalization at 1 to 36 hours following intravenous thrombolysis initiation. We present crude odds ratios (ORs) and ORs adjusted for the predefined variables of age, sex, baseline stroke severity, systolic blood pressure, and onset-to-treatment time.

Results:

We included 7 randomized controlled clinical trials that enrolled 1102 patients with AIS. A total of 138 and 134 confirmed large vessel occlusion patients were randomized to treatment and control groups respectively. Patients randomized to sonothrombolysis had increased odds of complete recanalization compared with patients receiving intravenous thrombolysis alone (40.3% versus 22.4%; OR, 2.17 [95% CI, 1.03–4.54]; adjusted OR, 2.33 [95% CI, 1.02–5.34]). The likelihood of symptomatic intracranial hemorrhage was not significantly different between the 2 groups (7.3% versus 3.7%; OR, 2.03 [95% CI, 0.68–6.11]; adjusted OR, 2.55 [95% CI, 0.76–8.52]). No differences in the likelihood of asymptomatic intracranial hemorrhage, 3-month favorable functional and 3-month functional independence were documented.

Conclusions:

Sonothrombolysis was associated with a nearly 2-fold increase in the odds of complete recanalization compared with intravenous thrombolysis alone in patients with AIS with large vessel occlusions. Further study of the safety and efficacy of sonothrombolysis is warranted.

Tuesday, August 27, 2019

Post-stroke rehabilitation cost with traditional therapy: Evidence from a public hospital

Survivors don't give a damn about costs. They want to know which hospital and doctors will get them 100% recovered.  Useless research. 

Post-stroke rehabilitation cost with traditional therapy: Evidence from a public hospital

Authors: Trung Quang Vo  ( Department of Economic and Administrative Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam )
Phuong Hong Le  ( Department of Pharmacy Administration, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam )

Abstract

Objective: After surviving from an acute phase of stroke, it is essential for stroke survivors to continue therapies to improve their function and quality of life. The aim of this study was to assess the influence of rehabilitation treatment on the society in economic aspect with evidence from a traditional hospital.
Methods: A prospective cohort study was carried out with patients who were being treated at Traditional Medicine Hospital in Ho Chi Minh City after experiencing a stroke. Patients' relevant medical information was extracted from the hospital's database and placed on a structured questionnaire.
Results: Among 103 eligible patients aged 60.3 } 11.4 years, 93.2% had experienced a stroke for the first time. Eighty-four patients were diagnosed with ischaemic stroke, while the number of haemorrhagic stroke patients was approximately 4.5 times lower (n = 19). The mean total cost was $3,310.40 USD, which included $1,653.60 USD, $539.90 USD and $1,117.00 USD for direct medical, direct non-medical and indirect cost, respectively. Hospital bed costs accounted for a considerable percentage of direct medical costs (41.0%).
Conclusion: Stroke was determined to be a significant social burden, although patients in this study had already suffered from the acute phase. This study gives decision makers a comparative view about the economic view on the economic burden of the stroke rehabilitation treatment between using traditional national Western and Eastern therapy.
Keywords: Economic cost, Rehabilitation, Stroke, Traditional therapy, Vietnam. (JPMA 69: S-87 (Suppl. 2); 2019)

Introduction

Stroke was found to be the deadliest cardiovascular disease in Vietnam during 2013 and the world's second biggest killer, accounting for more than six million deaths in 2015.1 Of the three types of stroke such as - ischaemic heart disease stroke, haemorrhagic stroke and transient ischaemic attack (TIA), the ischaemic stroke is the most common at 87%.2  In addition to its prevalence, stroke is renowned for its abruptness, high mortality and serious sequelae. Despite the fact that advances in the technological and medical treatment of stroke, as well as in the systems for delivering care, have improved stroke mortality rates, 3  many stroke survivors still experience relentless motor symptoms that affect their functional independence in daily life. 4  According to an observation from the Framingham Heart Study of the National Heart, Lung, and Blood Institute in the United States of America (NHLBI), 50% of ischaemic stroke patients who were at least 65 years old had some hemiparesis, 30% were unable to walk without some assistance, 26% were dependent in activities of daily living, 19% had aphasia, 35% had depressive symptoms and 26% were institutionalized in a nursing home. 5  A 2011 study by Godwin et al. which conducted with 54 patients in five hospitals in Southeast Texas found that the average cost per case of outpatient stroke rehabilitation services (included in physical therapy, occupational therapy, and speech therapy that were delivered in outpatient facilities and in the home) and medications for the first year after inpatient rehabilitation discharge was $17,081 USD (United State Dollars), while the total cost for outpatient expenses such as home healthcare, physician services, drugs, and durable medical equipment in 2010 reached approximately $10.1 billion USD. 6  Since strokes affect the brain, it is essential for stroke survivors to continue rehabilitation therapies after treatment with the aim of boosting independent movement, because these approaches can help them improve their muscle strength and coordination. In a country like Vietnam with their reputation about traditional therapy, rehabilitation phase using speech therapy, occupational therapy, as well as other experimental therapies, namely massage, acupuncture, herbal therapy, etc can teach patients how to use mobility aids and promote mental and emotional adjustment through. To provide accurate and timely information about the economic impacts of stroke rehabilitation and to estimate the economic burden of stroke recuperation with traditional therapy, this study presents the estimates and determinants of specific costs using a societal perspective and based on the findings from a crosssectional study.

Material/Subjects/Patients and Methods

This study was a prevalence-based cost-of-illness analysis in 2017 from different perspectives. A cross-sectional approach was conducted to estimate the cost per case and the total expense of stroke rehabilitation in Traditional Medicine Hospital in Ho Chi Minh City, which is one of the leading medical centres in using Eastern therapies serving approximately 1,000 patients' visits every day in Ho Chi Minh City and the surrounding provinces in the middle and south regions of Vietnam. This study considered inpatients who had been admitted to Ho Chi Minh City Traditional Medicine Hospital between Jan 2017 and December 2017 for treatment of post-stroke, according to ICD-10 (International Classification of Diseases, Tenth Revision) with code I69. All eligible participants voluntarily confirmed their consent and agreement after being informed about the content and objective of the research. All relevant patient data — comprising general information (age, gender, weight, height, locality and health insurance), medical services and medication used — were entered into the hospital database. This research design and methodology was approved by the ethics committee of the hospital, to allow researchers to access the necessary materials. A questionnaire was constructed to accumulate details from both patients and family members for the purpose of calculating the cost that society incurred due to the direct effect of stroke rehabilitation. The questionnaire consisted of two parts: one to record sociodemographic characteristics (occupation, education, monthly income, the number of strokes suffered and the number of caregivers) and one to record direct non-medical component costs (meals, accommodation and travel). Caregivers were divided into unpaid caregivers (who were family members of the patients) and hired caregivers (who were employed to take care of patients). Researchers also defined the amounts for salary and pension in monthly income, to have an accurate appraisal of each cost element. Economic burden was computed under patient, payer (health insurance company), hospital and social perspective, respectively. 71  The total cost was sum of the direct medical costs, the direct non-medical costs and indirect costs. All cost values were calculated in Vietnamese Dong (VND) currency, then converted to U.S. dollars by using the exchange rate 22,498 VND = $1 USD. 8  Direct cost included in direct medical cost and direct nonmedical cost. Direct medical cost was calculated from the intervention and unit cost which were extracted from data resources to assess the payment required from patients and health insurance companies. The results would measure cost components by grouping them into imaging diagnosis, laboratory tests, hospital beds, medication, herbal remedies, acupuncture, physical therapy and other costs (oxygen, ambulance, etc.). 9  Regarding direct non-medical cost, based on the answers of patients or their caregivers, accommodation and travelling cost were computed (Figure-1).



This study calculated direct costs according to the following equation:



The variables n, m and p represented the number of patients, caregivers and interventions. QI, UI, MP, LS and CD were abbreviations for quantities ofinterventions, unit cost of intervention, meal cost per day, length of stay and caregivers' nursing day, respectively. AC represents the accommodation of caregivers, and TV represents the travel costs for patients and caregivers.9 Absenteeism was defined as the amount of salary missed because of patients' hospitalization, which was calculated by multiplication between the length of stay (LS) and monthly income (MI). Reduced productivity from nonsalary patients was estimated based on expenses per month (EX). The population included retired people and adults who were in the typical workforce age range but who did not have a regular monthly income, such as unemployed workers, housewives, etc. The caregiver burden was computed using a summary of the hired caregivers' income lost because of dropping out of the workforce to provide care. For unpaid caregivers it was calculated by the amount of their salary missed from days off attributed to taking care of post-stroke patients. The indirect cost was computed by the formula below (Elliott & Payne, 2005)9:



The variables n, m and q were the number of patients, paid caregivers and unpaid caregivers. LS is an abbreviation for length of stay, MI refers to monthly income and EX refers to expenses. PCD are PMI are abbreviations for paid caregivers' nursing days and monthly income, respectively; CD and CMI represent unpaid caregivers' nursing days and monthly income, respectively.
Statistical Analysis: Data management and analysis was completed using the statistical software R version 3.4.3. Descriptive statistics handled the output of demographical characteristics. Bootstrap method with 95% CI (confident intervals) was used to control the natural skewness of cost data to increase the accuracy of the average cost per patient. The study applied t-tests and ANOVA when appropriate to evaluate the association between the mean cost and general features (age range, gender, location, education, BMI range, occupation, type of stroke, the number of strokes suffered and the number of comorbidities), which were arranged as categorical variables.
Ethics Statement: The Ho Chi Minh City Traditional Medicine Hospital Ethical Committee reviewed the study protocol, the questionnaire and the information letter for participants, and approved them in 2017 (No. 24/2017/YHCT). Data were analysed anonymously. Verbal informed consent was obtained from all persons that complied with our inclusion criteria and agreed via telephone to participate in the survey. Verbal consent was considered sufficient, as the survey was conducted without any physical or psychological intervention.

Results



Table-1 illustrates the demographic information of afterstroke rehabilitation patients who took part in the survey. It is clearly shown that more than half of the 103 participants were male (n = 61), with the mean age of 60.3 } 11.4 years. In addition, 68% of patients (n = 70) came from urban areas, and most of them were sellers (n = 31, 30.1%). In terms of the clinical record, 93.2% of the patients had no prior history of stroke, and 84 out of 103 people were diagnosed with ischaemic stroke. Although all the recorded patients had health insurance, the coverage percentages varied among them. It was recorded that the mean length of stay was 137.0 } 94.6 days. Regarding patients' comorbidity, the data depicts that most of the patients (n = 88) were also treated for hypertension (Table-1). Our conducted survey also collected data on the economic burden of post-stroke rehabilitation in Traditional Medicine Hospital, which are shown in Table-2 and illustrated within Figure-2.





The economic burden was computed as $342,303.50 USD, and the average total expenditure per case was $3,310.40 USD. Economic burden of post-stroke from social perspective [2017, USD, Arithmetic mean (Bootstrap 95% CI) (Table-2).

Effect of Cost Components on Total Cost of
Stroke Rehabilitation Patients



Table-3 depicts the average expenditure according to the demographic figures mentioned in the Table-1,



Figure-3 describes the direct medical costs determined by the mentioned social demographic characteristics (Table-3). Cost per case by demographical characteristics [n=103, 2017, USD, Arithmetic mean (Bootstrap 95% CI)] (Figure-3). Direct medical cost by demographic characteristics is shown in Figure-4 which illustrates costs from patient, payer, hospital and society perspectives. Society witnessed the economic burden of post-stroke rehabilitation with the total recorded cost of $342,303.00 USD, approximately two times higher than the hospital's cost. Economic burden under distinguished perspective can be seen in Figure-4.



Discussion

The mean age of patients in this study was 60.3 } 11.4 years, with 44.7% patients being younger than 60 years old, which is a lower age range than in previous studies on this topic. For example, the age ranges in Giovanni Fattore et al.,10 M van Eeden et al.11 and Charles Ellis et al.12 were 69.0 } 12.9, 66.8 } 12.3 and 78.1 } 6.9, respectively. In 2012, the AHA (American Heart Association) presented statistics showing that stroke patients were often more than 80 years old.13 The average length of stay of inpatient rehabilitation was 137.0 } 94.6 days. In other studies, patients were hospitalized from two to seven weeks after a stroke. 6,10,12 The significant difference could be explained by the fact that the populations of the other studies were mostly outpatients or patients evaluated after discharge, and this study was conducted in a traditional hospital. In this study, 84% of the patients were diagnosed with ischaemic stroke, and this percentage was at least 75% in a majority of stroke publications.6,10-12,14 Stroke rehabilitation had a direct impact on society with a cost of $342,303.50 USD, or $3,310.40 USD per patient. Because not only was there a variety of cost-analysis methodology in the study design, but also this study was conducted in a hospital that uses both Eastern and Western therapy, it was incommensurable with the estimated values of the economic burden as presented in other articles. Akhavan Hejazi SM et al.14 showed that the direct cost for outpatient rehabilitation during the first three months was $547.10 USD, corresponding with $548.38 USD in our results (which consisted of $1,653.60 USD for direct medical and $539.90 USD for direct nonmedical costs). Moreover, traditional therapy mentioned as an additional treatment outside the hospital for 69.4% patients amounted to $14.60 USD per session, which was more than double the price of a treatment session in hospital ($5.67 USD), whereas, it accounted for 45.9% direct medical cost in our assessment.14 An Italian study10 computed a cost of €4,112 EUR (euro) ($4,701 USD) in healthcare services for rehabilitation in the first twelve months. Some publications considered indirect cost to summarize the society's economic burden. M van Eeden et al. claimed that a post-stroke Dutch patients had productivity losses of €3,003.10 EUR (3,434 USD) and inability to do unpaid labour of €3,000.00 EUR (3,430 USD)11 while an Italian patient lost €792 EUR (905.68 USD) per stroke survivor because of the decrease of production,10 and the corresponding figure of Vietnamese patients from our results was $874.80 USD. Although the methodology was constructed carefully, there were some limitations in this study. The cost calculated was based on the information supplied by family members or patients, so some mistakes or missing values could be identified in estimating the economic burden. In spite of being cautious, the cost elements that belong to comorbidities could not be eliminated completely. Moreover, traditional therapy is very common in Vietnamese medical centres, but our study solely researched a small population in  one hospital, although it has a strong reputation for Eastern treatment in Vietnam. An idea for future researchers is to expand the sample size in multiple centres to more accurately appraise economic burden. Another approach would be to assess the cost and effectiveness of stroke rehabilitation and the quality of life for patients in both modern and traditional hospitals to have a comparative view for policymakers.

Conclusion

The study concluded that strokes had a significant effect on patients and caregivers, although in this case patients had already overcome the acute phase. Treatment and rehabilitation were a social burden not only in terms of the reduction of human source, but also in terms of the great amount of treatment cost. The method of this research was designed in a traditional hospital, and it could give decision makers a new perspective about economic burden of poststroke patients who followed traditional regiments.

Acknowledgement The authors also acknowledge the efforts of the research assistants at Ho Chi Minh city Traditional Medicine Hospital for communicating with study participants and collecting data. We are grateful to all study participants for giving us time at their residence and for their cooperation.
Disclaimer: None to declare.
Conflict of Interest: The authors declare that they have no conflict of interests.
Funding Disclosure: None to declare.

References

1. World Health Organization. The top 10 causes of death. News release. The WHO's Media Centre. [Online] 2018. Available from URL: http://www.who.int/mediacentre/factsheets/fs310/en/
2. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 2017;135:e146-e603.
3. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/ American Stroke Association. Stroke 2014;45:315-53.
4. Nichols-Larsen DS, Clark PC, Zeringue A, Greenspan A, Blanton S. Factors influencing stroke survivors' quality of life during subacute recovery. Stroke 2005;36:1480-4.
5. Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D'Agostino RB, Wolf PA.The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis 2003;12:119-26.
6. Godwin KM, Wasserman J, Ostwald SK. Cost associated with stroke: outpatient rehabilitative services and medication. Top Stroke Rehabil 2011;18(Suppl 1):S676-84.
7. Riewpaiboon A. Measurement of costs for health economic evaluation. J Med Assoc Thai 2014;97(Suppl 5):S17-26.
8. The State Bank of Vietnam. Central Rate of VND Versus USD. [Online] 2018. Available from URL: https://www.sbv.gov.vn/webcenter/portal/en/home/rm/er?_afrLoop=844029311933000#%40%3F_afrLoop%3D844029311933000%26centerWidth%3D80%2525%26leftWidth%3D20%2525%26rightWidth%3D0%2525%26showFooter%3Dfalse%26showHeader%3Dfalse%26_adf.ctrlstate%3Damnaec5p4_4
9. Elliott R, Payne K. Essentials of Economic Evaluation in Healthcare. London, UK: Pharmaceutical Press, 2005.
10. Fattore G, Torbica A, Susi A, Giovanni A, Benelli G, Gozzo M, et al. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol 2012;12:137.
11. van Eeden M, van Heugten C, van Mastrigt GAPG, van Mierlo M, Visser-Meily JMA, Evers SMAA. The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke. BMJ 2015;5:e008220.
12. Ellis C, Simpson AN, Bonilha H, Mauldin PD, Simpson KN. The one-year attributable cost of poststroke aphasia. Stroke 2012;43:1429-31.
13. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015;131:e29-322.
14. Akhavan Hejazi SM, Mazlan M, Abdullah SJ, Engkasan JP. Cost of poststroke outpatient care in Malaysia. Singapore Med J 2015;56:116-9.
Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees:

Monday, October 29, 2018

End of life after stroke: A nationwide study of 42,502 deaths occurring within a year after stroke

Our stroke associations should be following every stroke patient to find out their end recovery or death. I don't care that this would mean following 10 million yearly stroke survivors. Only by doing this will we get objective data to analyze and make recovery better. But your fucking failures of stroke associations doesn't give a damn because they are just worried about what that next press release is going to say.  World Stroke Day here we come with awareness crapola. 

End of life after stroke: A nationwide study of 42,502 deaths occurring within a year after stroke 


First Published October 6, 2017 Research Article



In the scientific literature, there is very limited empirical information on end-of-life issues after stroke in the scientific literature. The present nationwide study describes the circumstances surrounding deaths that occur within a year after a stroke.

Datasets from three nationwide Swedish registers (on stroke, palliative care and cause of death) were linked. Basic information was available for 42,502 unselected cases of death that occurred within a year after a stroke and more detailed information was available for 16,408 deaths. Odds ratios for characteristics of end-of-life care were calculated by logistic regression.

In the late phase after stroke (three months to one year), 46% of patients died in a nursing home, whereas 37% of patients died in a hospital after readmission and 10% of patients died at home. Eleven per cent of deaths were reported as being unexpected. A next of kin was present at 49% of deaths. The frequency of unattended deaths (neither next of kin nor staff were present at the time of death) ranged from 5% at home with specialised home care to 25% in hospitals.

This is, by far, the largest study published on end-of-life issues after stroke. Major differences between countries in healthcare, community services, family structure and culture may limit direct transfer of the present results to other settings.

There is considerable discordance between presumed ‘good death’ late after stroke (dying at home surrounded by family members) and the actual circumstances at the end of life.

Monday, May 28, 2018

Quality Indicators Highlight Sex Differences in Stroke Care

Survivors don't give as damn about 'care', they want results. So start measuring results you blithering idiots. Oops, I shouldn't speak like that to supposedly smarter persons than me.

Quality Indicators Highlight Sex Differences in Stroke Care

GOTHENBURG, Sweden — Door-to-needle time less than 60 minutes, arrival at a stroke unit before 4 hours, and use of thrombectomy were among quality measures that men were more likely to experience than women in a study of more than 83,000 hospital admissions for acute stroke.
Men were also more likely to receive a swallow screen within 4 hours, physiotherapy assessment within 72 hours, and early supported discharge compared with women in the study, which received the Paola De Rango award here at the 4th European Stroke Organisation Conference (ESOC) 2018.
The new findings "are somewhat surprising given that 10 years ago we looked at the same data and found no evidence of a difference," (Age Ageing. 2007;36:247-455) George Dunn, senior project coordinator of the Sentinel Stroke National Audit Programme at the Royal College of Physicians in London, UK, told Medscape Medical News. "A lot has changed in stroke care since then, but because this is such an important issue, we decided to look again."
"There were no quality measures that favored females," he added.
However, the study showed five measures with no evidence favoring men or women, including receipt of a brain scan within 1 hour and stroke nursing care within 24 hours. Another three 72-hour measures were not different: occupational therapy assessment; speech and language therapist assessment; or swallow assessment.
The research adds data to a body of literature without consensus. "Some studies suggest poorer care by women while others suggest equivalent care," he said.
The findings are based on 83,484 admissions for acute stroke from April 2016 to March 2017. All admissions were prospectively recorded in the Sentinel Stroke National Audit Programme (SSNAP), a national quality stroke register for England, Wales, and Northern Island. The patient population was 49% women.
Men were favored by a small amount versus women on measures including arrival at a stroke unit within 4 hours, received a swallow screen within 4 hours, or received early supported discharge. However, the researchers reported more pronounced differences for receiving thrombolysis, door-to-needle time within 60 minutes, and physiotherapy within 72 hours.
Table. Stroke Treatment Indicators for Women vs Men
Endpoint Adjusted OR   95% CI
Arrival at stroke unit within 4 h 1.04 1.01 - 1.07
Swallow screen within 4 h 1.05 1.01 - 1.10
Early supported discharge 1.05 1.01 - 1.08
Receiving thrombolysis 1.10 1.05 - 1.15
Door-to-needle time within 60 min 1.15 1.05 - 1.25
Physiotherapy within 72 h 1.11 1.03 - 1.19
CI: confidence interval; OR: odds ratio.
Median age at admission was 74 years among men and 80 years among women. "Women have stroke at an older age — both for hemorrhagic and ischemic stroke," Dunn said.
Diabetes was more prevalent among men and atrial fibrillation was more prevalent among women. "We expect this is likely due to the older age of females suffering stroke," he added.
The researchers chose the 11 prespecified measures of quality in acute stroke care before analyzing the data. They adjusted their findings for age, stroke type, atrial fibrillation, diabetes, hypertension, heart failure, longer time to hospital for women, and other factors.
Study strengths included a large number of cases, data entered using a secure web tool that allows internal validation, and complete geographic coverage of three countries (representing about 95% of acute stroke admissions). Only assessing acute care and not assessing outcomes were limitations.
The findings are "worrying," Dunn said. "We think more research should be done to make sure the data are consistent, and if so, steps should be taken to rectify the situation, because clearly this is unfair."
"It was a well-done study — the design and sample size of more than 80,000 people. It's quite impressive," said Valery Feigin, MD, PhD, director of the National Institute for Stroke and Applied Neurosciences School of Rehabilitation and Occupation Sciences at the Auckland University of Technology in New Zealand, commenting on the study for Medscape Medical News.
"I think the most important finding from the study is that there was a difference in favor of men in getting rehabilitation earlier and time to needle was shorter, which is a very big predictor of outcomes," Feigin added. "It's a very important study that could explain why men have better outcomes."
Dunn and Feigin have reported no relevant financial relationships.
4th European Stroke Organisation Conference (ESOC) 2018. Presented May 17, 2018.
Follow Damian McNamara on Twitter: @MedReporter. For more from theheart.org | Medscape Cardiology, follow us on Twitter and Facebook.